Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar;18(3):547-548.
doi: 10.4103/1673-5374.350200.

Axon degeneration: new actor in an old play

Affiliations

Axon degeneration: new actor in an old play

Marina Herwerth et al. Neural Regen Res. 2023 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

None

Figures

Figure 1
Figure 1
Early phase of axon degeneration can appear in different forms. (A) Established programs of axon degeneration (such as Wallerian degeneration or focal acute axonal degeneration) are calcium-dependent and are finally characterized by the following sequence of events: Initial injury trigger leads to an abnormal calcium influx through mechanochannels/nanopores (1) and calcium release from internal calcium stores, such as mitochondria and axoplasmic reticulum (2). The increase in intra-axonal calcium level activates calcium-dependent calpain proteases (3) that lead to cytoskeletal breakdown and eventually cargo accumulation (4), such as mitochondria and NMNAT2. (B) Astrocytopathy-driven axonal beading has characteristics that distinguish it from the other described pathways. After the lytic depletion of astrocytes (1), a sodium influx-related osmotic challenge (2) induces remodeling of the microtubular cytoskeleton (3) in the initial state without overt cargo accumulation (4). The described processes affect both myelinated and non-myelinated axons. However, for better readability of the figure, the myelin layer has been omitted in the inset illustrations. AQP4: Aquaporin 4 channel; AR: axoplasmic reticulum; MI: mitochondria; MT: microtubules; NMNAT2: the protein nicotinamide mononucleotide adenylyltransferase 2. Created with BioRender.com.

References

    1. Carnero Contentti E, Correale J. Neuromyelitis optica spectrum disorders:from pathophysiology to therapeutic strategies. J Neuroinflammation. 2021;18:208. - PMC - PubMed
    1. Coleman MP, Hoke A. Programmed axon degeneration:from mouse to mechanism to medicine. Nat Rev Neurosci. 2020;21:183–196. - PMC - PubMed
    1. Herwerth M, Kalluri SR, Srivastava R, Kleele T, Kenet S, Illes Z, Merkler D, Bennett JL, Misgeld T, Hemmer B. In vivo imaging reveals rapid astrocyte depletion and axon damage in a model of neuromyelitis optica-related pathology. Ann Neurol. 2016;79:794–805. - PMC - PubMed
    1. Herwerth M, Kenet S, Schifferer M, Winkler A, Weber M, Snaidero N, Wang M, Lohrberg M, Bennett JL, Stadelmann C, Hemmer B, Misgeld T. A new form of axonal pathology in a spinal model of neuromyelitis optica. Brain. 20222022:awac079. - PMC - PubMed
    1. Hughes RO, Bosanac T, Mao X, Engber TM, DiAntonio A, Milbrandt J, Devraj R, Krauss R. Small molecule SARM1 inhibitors recapitulate the SARM1(-/-) phenotype and allow recovery of a metastable pool of axons fated to degenerate. Cell Rep. 2021;34:108588. - PMC - PubMed